Nicholas Maestas
Director of Finance/CFO chez TEMPEST THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Postes actifs de Nicholas Maestas
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Director of Finance/CFO | 12/07/2021 | - |
| Corporate Secretary | 30/09/2022 | - |
Historique de carrière de Nicholas Maestas
Anciens postes connus de Nicholas Maestas
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALECTOR, INC. | Corporate Officer/Principal | 01/07/2019 | 01/07/2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 01/11/2014 | 01/07/2019 |
Formation de Nicholas Maestas
| University of California, Berkeley | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALECTOR, INC. | Health Technology |
| TEMPEST THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
- Bourse
- Insiders
- Nicholas Maestas
- Expérience
